Back to Schemes

Ovarian and Prostate Cancer (PARPi) [Tissue, Somatic]

Product Code: PARP(S)-25

From £285.00

Registration closed: 28/02/2025

Applicable to any lab undertaking somatic molecular testing of BRCA1, BRCA2 and other Homologous Recombination Repair (HRR) genes in the context of PARPi prescription, using FFPE tissue.

Target/Genes:

Variants in the BRCA1BRCA2 and other HRR genes.

Technology:

Any molecular test, NGS, Panel testing, Targeted testing, Whole exome sequencing

Language:

English

Sample Type:

FFPE (artificial materials)

Accredited:

Yes

EQA Assessment

The scheme is designed to assess the analytical process (genotyping), and reporting (biological and clinical interpretation of the test result) including the overall report layout, content and clerical accuracy.

Participants will receive an individual report including educational advice and a scheme summary report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics which allow participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Sample Details

Three mock clinical cases with matching samples. Samples provided are real human tumour tissue paraffin embedded (FFPE) and artificial FFPE (designed to simulate real patient samples). One 10um FFPE section per case is provided.

Samples are provided as cut sections (rolled scrolls / curls) only – we cannot provide slide mounted materials.

EQA Results

Participants will receive an individual report including educational advice and a scheme report which includes additional information from the cohort of participants including geographical spread, methodologies employed, common errors, learning points and scheme statistics allowing participants to benchmark their results.

Each laboratory will also receive a single certificate listing all EQAs participated in with performance result for each year.

Participation Information

This EQA is supported by an educational grant from AstraZeneca and MSD, fees are subsidised so there is a reduced cost for participants. The EQA providers acknowledge and thank AstraZeneca and MSD for this support.

Number of participants is restricted, please register early to make sure you don’t miss out.

Open to laboratories from ALL countries (note: some restrictions may apply*)

*Sanctions, delivery network exceptions, restrictions on importation etc.

How it works

Register

  • Enrol before the closing date
  • EMQN ships EQA samples or digital cases

Test & submit results

  • Analyse samples in your routine workflow
  • Upload results via QA Manager

Review & get certified

  • EMQN benchmarks your data
  • Receive final report & Certificate of Participation

Enquire about this scheme

Contact Information

added wishlist!
View Wishlist

0

View Wishlist

Register Interest

Express your interest in ''.